STERIS STOCK IS GRADE "A" IN NOVEMBER AS WALL STREET ANTICIPATES BEEF IRRADIATION APPROVAL BY FDA; OTC INDEX OFF 1.5% FOR THE MONTH WITH 22 ISSUES DECLINING
This article was originally published in The Gray Sheet
Executive Summary
Steris stock turned in a beefy 18.2% gain to close at 47 for the month of November as bullish investors in the microbial reduction technologies concern anticipated FDA approval for irradiation ("cold pasteurization") of red meat, which occurred Dec. 2.